Results 201 to 210 of about 123,337 (299)
Background Drug‐coated balloons (DCBs) present a viable option distinct from drug‐eluting stents (DESs) in addressing coronary artery disease (CAD), particularly when it comes to in‐stent restenosis (ISR) scenarios. The utilization of DCBs marks a significant deviation from traditional DES applications.
Yue Yu +6 more
wiley +1 more source
Clinical Outcomes of Drug-Eluting Balloon for In-Stent Restenosis Based on the Number of Metallic Layers [PDF]
Hiroto Yabushita +19 more
openalex +1 more source
Clinical Efficacy of Atorvastatin Combined with Ezetimibe in Preventing Restenosis after Coronary Artery Bypass Grafting [PDF]
Run Sheng Wei +3 more
openalex +1 more source
Local Hemodynamic Forces After Stenting: Implications on Restenosis and Thrombosis
J. Ng +6 more
semanticscholar +1 more source
Alagille syndrome is a rare multisystemic genetic condition most commonly associated with neonatal liver disease. Variable expressivity is a defining feature of Alagille syndrome, resulting in a broad spectrum of phenotypic variation among individuals who meet the diagnostic criteria. We present an atypical case of cardiac‐predominant Alagille syndrome
Matthew K. Campbell +4 more
wiley +1 more source
Correlation between hypertension and restenosis after endovascular therapy: a meta-analysis based on a derived cohort from randomized trials. [PDF]
Zhang C +5 more
europepmc +1 more source
Factors associated with restenosis after carotid artery stenting differ between closed-cell and open-cell stents. [PDF]
Liu Y +5 more
europepmc +1 more source
Proteomic Analysis and 2-Hydroxyisobutyrylation Profiling in Metabolic Syndrome Induced Restenosis
Xiangyu Liu +8 more
openalex +1 more source

